Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million […]
Envisagenics Raises Series A Financing to Scale its AI-powered RNA Splicing Drug Discovery Platform
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA […]
Prime Therapeutics and Pear Therapeutics Announce First Comprehensive Value-based Agreement for Prescription Digital Therapeutics reSET® and reSET-O® for the Treatment of Substance and Opioid Use Disorders
More than 20 million Americans struggle with drug addiction while only 10-20% receive treatment. Prime Therapeutics […]
Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer
Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering RNA cell therapy in and beyond […]
Avacta Group Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research
Larsen & Toubro Infotech (BSE: 540005, NSE: LTI), a global technology consulting and digital solutions company […]
Prime Therapeutics Welcomes Chris Knibb as Chief Financial Officer
Chris Knibb, an accomplished finance executive with more than 25 years of financial and business […]
ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”
ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, and […]
New Startup Aglaia Therapeutics Raises €4m in Seed Funding to Overcome Resistance in Oncology Targeted Therapies
Aglaia Therapeutics, a biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies […]
Hikma Strengthens US Injectables Business Through Acquisition of Custopharm
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more